Back to results
US 2023/0140937 A1Published application
Methylation markers and targeted methylation probe panel
AssigneeGrail, LLC
InventorsSamuel S. GROSS, Oliver Claude VENN, Seyedmehdi SHOJAEE, John BEAUSANG, Arash JAMSHIDI
Life of this patent
Estimating the term…
Abstract
The present description provides a cancer assay panel for targeted detection of cancer-specific methylation patterns. Further provided herein are methods of designing, making, and using the cancer assay panel for the diagnosis of cancer.
Claims19
A mixture for processing cell-free DNA fragments, the mixture comprising (a) converted cell-free DNA (cfDNA) molecules or amplification products thereof;
- and (b) a panel of different oligonucleotide probes configured to hybridize to converted cell-free DNA fragments derived from at least 500 target genomic regions;
- wherein the converted cfDNA molecules comprise deaminated nucleotides obtained by treating cfDNA molecules with a deaminating agent;
- wherein each target genomic region of the at least 500 target genomic regions has an anomalous methylation pattern in cancerous samples;
- and
- wherein each of the at least 500 target genomic regions comprises a sequence with complementarity to at least a pair of probes in the panel, wherein each probe of a pair has a first portion and a second portion, wherein the first portions of a probe pair are complementary to the same sequence of at least 25 nucleotides in length, and wherein the second portions of a probe pair are complementary to different sequences at different ends of the sequence complementary to the respective first portions.
2 more elements
Dependencies are inferred from the claim text.